Predictive Oncology Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
POAI Nasdaq 2830 predictive-oncology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Predictive Oncology Inc.

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - Jun 12th, 2025 6:30 am
Court Denies Renovaro Motion for an Expedited Trial in July - May 27th, 2025 6:35 am
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - May 22nd, 2025 1:12 pm
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - May 22nd, 2025 9:05 am
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition - May 22nd, 2025 6:15 am
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health" - May 20th, 2025 6:30 am
Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update - May 15th, 2025 5:00 am
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs - Apr 15th, 2025 6:00 am
China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz - Apr 5th, 2025 10:10 am
Renovaro Provides Update to Definitive Agreement with Predictive Oncology - Apr 4th, 2025 7:40 am
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - Apr 1st, 2025 5:00 am
Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research - Mar 27th, 2025 3:33 pm
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - Mar 25th, 2025 5:00 am
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - Mar 20th, 2025 5:00 am
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - Mar 3rd, 2025 7:15 am
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - Mar 3rd, 2025 7:00 am
Predictive Oncology Closes Registered Direct Offering - Feb 19th, 2025 3:20 pm
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Feb 19th, 2025 6:00 am
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing - Feb 18th, 2025 6:00 am
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis - Feb 10th, 2025 6:00 am